Heng Lu

919 total citations
32 papers, 629 citations indexed

About

Heng Lu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Heng Lu has authored 32 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Surgery and 10 papers in Oncology. Recurrent topics in Heng Lu's work include Helicobacter pylori-related gastroenterology studies (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and RNA modifications and cancer (5 papers). Heng Lu is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and RNA modifications and cancer (5 papers). Heng Lu collaborates with scholars based in United States, China and Italy. Heng Lu's co-authors include Wael El‐Rifai, Zheng Chen, Dunfa Peng, Mohammed Soutto, Shoumin Zhu, Richard M. Peek, Nadeem S. Bhat, Ajaz A. Bhat, Alexander Zaika and Zekuan Xu and has published in prestigious journals such as Gastroenterology, Cancer Research and Oncogene.

In The Last Decade

Heng Lu

31 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Lu United States 16 368 160 152 145 126 32 629
Zhenfeng Guan China 14 358 1.0× 167 1.0× 111 0.7× 185 1.3× 121 1.0× 25 643
Xigan He China 12 459 1.2× 327 2.0× 106 0.7× 125 0.9× 114 0.9× 28 706
Leping Yang China 17 398 1.1× 229 1.4× 117 0.8× 195 1.3× 108 0.9× 41 725
Songtao Lai China 11 314 0.9× 168 1.1× 96 0.6× 251 1.7× 90 0.7× 21 645
Chun-Ying Qu China 14 271 0.7× 152 0.9× 62 0.4× 104 0.7× 97 0.8× 25 563
Taohua Yue China 15 330 0.9× 174 1.1× 60 0.4× 144 1.0× 143 1.1× 24 607
Changhao Liu China 15 366 1.0× 204 1.3× 62 0.4× 110 0.8× 68 0.5× 46 682
Wenhua Zhan China 14 352 1.0× 175 1.1× 84 0.6× 186 1.3× 117 0.9× 41 720
Jiazhang Wei China 14 324 0.9× 194 1.2× 46 0.3× 126 0.9× 75 0.6× 46 606
Xianqing Jin China 13 325 0.9× 191 1.2× 153 1.0× 156 1.1× 61 0.5× 52 641

Countries citing papers authored by Heng Lu

Since Specialization
Citations

This map shows the geographic impact of Heng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Lu more than expected).

Fields of papers citing papers by Heng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Lu. The network helps show where Heng Lu may publish in the future.

Co-authorship network of co-authors of Heng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Lu. A scholar is included among the top collaborators of Heng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Lu. Heng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Heng, Weidong Wu, Ji Li, & Xiaoyan Xu. (2025). Effects of Bifidobacterium triple viable bacteria-assisted mirtazapine in managing depression in patients after radical surgery for gastric cancer. World Journal of Gastrointestinal Surgery. 17(4). 100821–100821.
2.
Chen, Lei, Heng Lu, Farah Ballout, et al.. (2025). Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors. International Journal of Molecular Sciences. 26(5). 1992–1992. 1 indexed citations
3.
Shi, Yue, Heng Lu, & Yiqi Zhang. (2024). Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Research and Treatment. 206(2). 387–395. 2 indexed citations
4.
Ballout, Farah, Heng Lu, Nadeem S. Bhat, et al.. (2024). Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair. Clinical Cancer Research. 30(10). 2193–2205. 2 indexed citations
5.
6.
Lu, Heng, Farah Ballout, Abbes Belkhiri, et al.. (2023). Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma. Gut. 73(1). 47–62. 17 indexed citations
7.
Chen, Lei, Farah Ballout, Heng Lu, et al.. (2023). Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus. Cancers. 15(19). 4821–4821. 5 indexed citations
8.
Soutto, Mohammed, Xing Zhang, Nadeem S. Bhat, et al.. (2023). Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis. Redox Biology. 69. 102998–102998. 7 indexed citations
9.
Chen, Lei, Heng Lu, Dunfa Peng, et al.. (2022). Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma. Gut. 72(3). 421–432. 19 indexed citations
10.
Cao, Long‐Long, Shoumin Zhu, Heng Lu, et al.. (2022). Helicobacter pylori–induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis. Gastroenterology. 162(6). 1716–1731.e17. 59 indexed citations
11.
Ballout, Farah, Heng Lu, Lei Chen, et al.. (2022). APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas. Journal of Experimental & Clinical Cancer Research. 41(1). 264–264. 13 indexed citations
12.
13.
Peng, Dunfa, Heng Lu, Nadeem S. Bhat, et al.. (2021). Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells. Redox Biology. 43. 101970–101970. 23 indexed citations
14.
Zhu, Shoumin, Zheng Chen, Dunfa Peng, et al.. (2020). Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer Letters. 491. 87–96. 8 indexed citations
15.
Zhang, Yiqi, et al.. (2020). <p>The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer</p>. OncoTargets and Therapy. Volume 13. 3437–3448. 14 indexed citations
16.
Lu, Heng, Ajaz A. Bhat, Dunfa Peng, et al.. (2019). APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma. Cancer Research. 79(17). 4426–4438. 20 indexed citations
17.
Peng, Dunfa, Heng Lu, Shoumin Zhu, et al.. (2019). NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells. Cancer Letters. 458. 46–55. 14 indexed citations
18.
Zhou, Zhangjian, Heng Lu, Shoumin Zhu, et al.. (2019). Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage. Journal of Experimental & Clinical Cancer Research. 38(1). 13–13. 26 indexed citations
19.
Bhat, Ajaz A., Heng Lu, Mohammed Soutto, et al.. (2018). Exposure of Barrett’s and esophageal adenocarcinoma cells to bile acids activates EGFR–STAT3 signaling axis via induction of APE1. Oncogene. 37(46). 6011–6024. 41 indexed citations
20.
Wason, Melissa S., Heng Lu, Yu Lin, et al.. (2018). Cerium Oxide Nanoparticles Sensitize Pancreatic Cancer to Radiation Therapy through Oxidative Activation of the JNK Apoptotic Pathway. Cancers. 10(9). 303–303. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenfeng Guan Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Leping Yang Breakdown of academic impact, for papers by Songtao Lai Breakdown of academic impact, for papers by Chun-Ying Qu Breakdown of academic impact, for papers by Taohua Yue Breakdown of academic impact, for papers by Changhao Liu Breakdown of academic impact, for papers by Wenhua Zhan Breakdown of academic impact, for papers by Jiazhang Wei Breakdown of academic impact, for papers by Xianqing Jin
Rankless by CCL
2026